Thu 25 Jun 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Changing Diabetes® World Tour | Novonordisk | Ongoing | N/A | 4 | version 6 - October 2010 | King Abdulaziz University Hospital (Jeddah) |
| A Prospective Observational Study on the home treatment of haemarthrosis with VIIa (activated recombinant factor VII) in haemophilia A and B patient with inhibitors | Novonordisk | Ongoing | NovoSeven (activated recombinant factor VII) | 4 | F7HEAM-3850 | King Khalid University Hospital (Riyadh) |
| DISCOVER Study - Drug Treatment Reality of Type 2 Diabetes in Real World Settings Internationally -D1690R00002 | AstraZeneca | Ongoing | N/A | 4 | D1690R0000 | King Fahad Medical City (Riyadh), Aseer Central Hospital, King Salman Bin AbdulAziz Hospital (Riyadh), Prince Mutaib Bin Abdul Aziz Hospital (Sakaka), King Khalid University Hospital (Riyadh), Armed Forces Hospital (khamis mushait), King Abdulaziz Hospital and Oncology Center (Jeddah), King Fahad Hospital (Jeddah) |
| Saudi rEgistry of Cardiovascular Risk factor managEmenT in HemoDialysis patients | Sanofi | Ongoing | N/A | 4 | 2 | King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah), King Khalid General Hospital (Hail), King Abdulaziz University Hospital (Jeddah), Al-Noor Specialist Hospital (Makkah), Dr. Soliman Fakeeh Hospital (Jeddah), King Salman Kidney Diseases Center (Riyadh) |
| A multicenter, observational, phase IV study of the use of Pregabalin (Nervax®) on adult patients for the management of Neuropathic pain in Saudi Arabia | Tabuk Pharmaceuticals | Ongoing | NERVAX | 4 | N-001 | King Fahad Medical City (Riyadh) |
| A multicenter, observational, prospective study of the use of Diclofenac Sodium 75 mg Dual Release Capsules (Divido®) on adult patients with persistent or chronic pain and inflammation in Saudi Arabia | Tabuk Pharmaceuticals | Ongoing | Divido | 4 | D-001 | King Fahad Medical City (Riyadh) |
| Multinational, Prospective, Observational Study to Assess the Unmet Medical Needs associated with Basal Insulin Use in Patients with Type 2 Diabetes Newly or Recently Initiated with Basal Insulin Treatment | Sanofi | Ongoing | N/A | 4 | OBS13780 | King Khalid University Hospital (Riyadh) |
| Evaluation of Asthma Management in Middle EAst North Africa Adult population ( ESMAA Study ) | AstraZeneca | Ongoing | N/A | 4 | RME-XXX-20 | Soliman Fakeeh Hospital (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah), Armed Forces Hospital (dhahran), King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Armed Forces Hospital (Taif), King Fahad Specialist Hospital (Dammam), International Medical Center (Jeddah), King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah) |
| Verifying Insulin Strategy and Initial Health Outcome Analysi | Eli Lilly | Ongoing | N/A | 4 | F3Z-MC-B01 | International Medical Center (Jeddah), King Fahd University Hospital (al khobar), King Fahad Medical (City), Armed Forces Hospital (Taif) |
| The Effect of Vitamin D3 on Biomarkers of Glycaemia and Oxidative Stress in Saudi Men with Poorly-Controlled Type 2 Diabetes Mellitus | King Fahad Medical City | Ongoing | Vitamin D Capsules | 4 | H-01-R-012 | King Fahad Medical City (Riyadh) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.